- $24.24m
- -$58.88m
- $2.41m
- 51
- 38
- 14
- 26
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.18 | ||
| Price to Tang. Book | 0.18 | ||
| Price to Free Cashflow | 17.94 | ||
| Price to Sales | 10.04 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.24% | ||
| Return on Equity | -12.32% | ||
| Operating Margin | -357.78% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 6.91 | n/a | 6 | 13.18 | 2.41 | n/a | n/a | -8.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- April 25th, 2016
- Public Since
- November 3rd, 2017
- No. of Employees
- 42
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Capital Market- Shares in Issue
- 68,598,050
- Address
- 5Th Floor,, BEIJING, 0000
- Web
- https://ir.xiaobaimaimai.com/
- Phone
- +86 1053709902
- Auditors
- Audit OneStop Assurance PAC
Upcoming Events for AHG
Similar to AHG
36Kr Holdings
NASDAQ Capital Market
3 E Network Technology
NASDAQ Capital Market
A2Z Cust2mate Solutions
NASDAQ Capital Market
Abits
NASDAQ Capital Market
Aegis Identity Software
NASDAQ Capital Market
FAQ
As of Today at 19:09 UTC, shares in Akso Health are trading at $1.06. This share price information is delayed by 15 minutes.
Shares in Akso Health last closed at $1.06 and the price had moved by -37.65% over the past 365 days. In terms of relative price strength the Akso Health share price has underperformed the S&P500 Index by -53.59% over the past year.
There is no consensus recommendation for this security.
Find out moreAkso Health does not currently pay a dividend.
Akso Health does not currently pay a dividend.
Akso Health does not currently pay a dividend.
To buy shares in Akso Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.06, shares in Akso Health had a market capitalisation of $24.24m.
Here are the trading details for Akso Health:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AHG
Based on an overall assessment of its quality, value and momentum Akso Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Akso Health is $3.00. That is 183.02% above the last closing price of $1.06.
Analysts covering Akso Health currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Akso Health. Over the past six months, its share price has underperformed the S&P500 Index by -0.78%.
As of the last closing price of $1.06, shares in Akso Health were trading -2.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Akso Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Akso Health's directors